Peter Radovich

2022

In 2022, Peter Radovich earned a total compensation of $1.6M as Chief Operating Officer at Mirum Pharmaceuticals, a 13% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$252,450
Option Awards$670,596
Salary$467,500
Stock Awards$158,700
Other$12,200
Total$1,561,446

Radovich received $670.6K in option awards, accounting for 43% of the total pay in 2022.

Radovich also received $252.5K in non-equity incentive plan, $467.5K in salary, $158.7K in stock awards and $12.2K in other compensation.

Rankings

In 2022, Peter Radovich's compensation ranked 2,156th out of 5,756 executives tracked by ExecPay. In other words, Radovich earned more than 62.5% of executives.

ClassificationRankingPercentile
All
2,156
out of 5,756
63rd
Division
Manufacturing
1,160
out of 3,133
63rd
Major group
Chemicals And Allied Products
500
out of 1,419
65th
Industry group
Drugs
460
out of 1,320
65th
Industry
Pharmaceutical Preparations
334
out of 966
65th
Source: SEC filing on May 1, 2023.

Radovich's colleagues

We found three more compensation records of executives who worked with Peter Radovich at Mirum Pharmaceuticals in 2022.

2022

Christopher Peetz

Mirum Pharmaceuticals

Chief Executive Officer

2022

Lara Longpre

Mirum Pharmaceuticals

Chief Development Officer

2022

Pamela Vig

Mirum Pharmaceuticals

Head of Research and Development

News

You may also like